Klaus W. Wagner - Net Worth and Insider Trading

Klaus W. Wagner Net Worth

The estimated net worth of Klaus W. Wagner is at least $4 Million dollars as of 2024-06-04. Klaus W. Wagner is the Chief Medical Officer of Inhibrx Inc and owns about 215,150 shares of Inhibrx Inc (INBX) stock worth over $4 Million. Details can be seen in Klaus W. Wagner's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Klaus W. Wagner has not made any transactions after 2021-02-17 and currently still holds the listed stock(s).

Transaction Summary of Klaus W. Wagner

To

Klaus W. Wagner Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Klaus W. Wagner owns 1 companies in total, including Inhibrx Inc (INBX) .

Click here to see the complete history of Klaus W. Wagner’s form 4 insider trades.

Insider Ownership Summary of Klaus W. Wagner

Ticker Comapny Transaction Date Type of Owner
INBX Inhibrx Inc 2021-02-17 Chief Medical Officer

Klaus W. Wagner Latest Holdings Summary

Klaus W. Wagner currently owns a total of 1 stock. Klaus W. Wagner owns 215,150 shares of Inhibrx Inc (INBX) as of February 17, 2021, with a value of $4 Million.

Latest Holdings of Klaus W. Wagner

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
INBX Inhibrx Inc 2021-02-17 215,150 17.35 3,731,777

Holding Weightings of Klaus W. Wagner


Klaus W. Wagner Form 4 Trading Tracker

According to the SEC Form 4 filings, Klaus W. Wagner has made a total of 1 transactions in Inhibrx Inc (INBX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Inhibrx Inc is the sale of 176,033 shares on February 17, 2021, which brought Klaus W. Wagner around $4 Million.

Insider Trading History of Klaus W. Wagner

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Klaus W. Wagner Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Klaus W. Wagner Ownership Network

Ownership Network List of Klaus W. Wagner

No Data

Ownership Network Relation of Klaus W. Wagner

Insider Network Chart

Klaus W. Wagner Owned Company Details

What does Inhibrx Inc do?

Who are the key executives at Inhibrx Inc?

Klaus W. Wagner is the Chief Medical Officer of Inhibrx Inc. Other key executives at Inhibrx Inc include director & 10 percent owner & Chief Scientific Officer Brendan P. Eckelman , 10 percent owner Ole Andreas Halvorsen , and 10 percent owner Viking Global Opportunities Parent Gp Llc .

Inhibrx Inc (INBX) Insider Trades Summary

Over the past 18 months, Klaus W. Wagner made no insider transaction in Inhibrx Inc (INBX). Other recent insider transactions involving Inhibrx Inc (INBX) include a net sale of 420,000 shares made by Brendan P. Eckelman , a net sale of 52,060 shares made by Mark Lappe , and a net sale of 19,000 shares made by Jon Faiz Kayyem .

In summary, during the past 3 months, insiders sold 300,000 shares of Inhibrx Inc (INBX) in total and bought 0 shares, with a net sale of 300,000 shares. During the past 18 months, 491,060 shares of Inhibrx Inc (INBX) were sold and 511,627 shares were bought by its insiders, resulting in a net purchase of 20,567 shares.

Inhibrx Inc (INBX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Inhibrx Inc Insider Transactions

No Available Data

Klaus W. Wagner Mailing Address

Above is the net worth, insider trading, and ownership report for Klaus W. Wagner. You might contact Klaus W. Wagner via mailing address: C/o Inhibrx, Inc., 11025 N. Torrey Pines Road, Suite 200, La Jolla Ca 92037.

Discussions on Klaus W. Wagner

No discussions yet.